Evolving Canada’s Health Care System for the 21st Century
Published on Macleans.ca

If you ask Canadians what values define our country, equal access to universal health care is near the top of the list. But those who know the system best say we could be doing a lot better.

Download this article to read all about Evolving Canada’s health care system for the 21st century and bringing everyone to the table.

Health Literacy

Health Literacy is important and getting the information you need shouldn’t be hard. Download this Health Literacy Campaign to read about real life examples of how institutions are making information more accessible to the public, how effective communication is a key driver to patient safety and more.

Presented by:

Future of Health Care

Take a look at what the future holds for Health Care. Download this 7 page special interest piece & read on for information on:

  • AI and Health Care
  • Population Health Challenge
  • 3D Printing & Glaucoma
  • Digital Tools for Holistic Care
  • Eyesight Through Cell Transplantation
  • Preventive care

Presented by:

Together We Can Improve Canadian Pharmacare

Equal and sustainable access for all to prescription drugs remains a dream rather than a reality in Canada, but the Market Access Summit brings the key players together to find a solution.

Case Study

Emilie’s Story – Preparing the best possible clinical and economic value proposition for your drug reimbursement file

Find out how you can adapt advisory board meetings to the dynamic needs of pharmaceutical market access today. Reinvent your follow-up and re-engage your advisors.

Download the Case Study for more information & ideas. Complete the form to your right.

Survey Report

Evaluating Current Barriers to Market Access in Canada

This survey was conducted September 2016 featuring responses from key market access professionals from across Canada and other pharma-industry stakeholders.

Focuses include:

  • Managing Costs
  • Patient Advocacy
  • Pricing
  • Government Incentives
  • Communication with Provincial Government

Bonus: This report also highlights additional suggestions and responses by survey respondents.

Get the detailed survey results by completing the form to your right.

Innomar – Dealing with the Expensive Shock of a Rare Disease

A recent CORD survey found that the median time to have a rare disease diagnosed is three to six years. If you are lucky enough to have a treatment for your condition, you may find yourself in sticker shock. Prescription drugs for rare diseases can cost in excess of hundreds of thousands of dollars or more per patient per year. In the same survey, over 70 percent of the patients indicated they had to incur personal costs for their treatment.

Fill out the form to read the entire report from Innomar.

Breaking through Silos

Read a Telus Health industry discussion paper to understand why bridging drug costs, health benefits and primary care is essential for Canada’s health.

Fill out the form to read the discussion.